White Papers
Understanding doctors' perspectives on DTx in India is crucial as they are pivotal in shaping patient adoption and adherence. Fitterfly’s survey on the advocacy of DTx among Indian doctors was conducted by scrutinizing 2877 prescriptions from 1897 members and analyzing the responses of 232 doctors across 99 cities. It supported the growing preference for DTx in metabolic disease management among Indian clinicians.